ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 178248 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 178248; 2) Community: the network communities that were significantly associated with the response to NSC 178248; 3) Molecule: the relationships between components within communities and NSC 178248; 4) MDR: the compounds that were significantly associated with the NSC 178248.

NSC Compound Enrichment Correlation
NSC 664303 Acetic acid, 1,1,1-trifluoro-2-(trifluoromethyl)-3-(2-quinolinyl)-2-propyl ester 0.0295480456086945 0.023081615
NSC 715572 Null 0.0295480456086945 0.031623656
NSC 357704 Cyanomorpholinodoxorubicin 0.0295480456086947 0.62439792
NSC 381867 BAFILOMYCIN ANTIBIOTIC 0.0295480456086947 0.27619702
NSC 623520 Null 0.0295480456086947 0.23700913
NSC 624512 Null 0.0295480456086947 -0.017101347
NSC 670765 Null 0.0295480456086947 0.0094137608
NSC 681239 Bortezomib 0.0295480456086947 0.028900089
NSC 681636 Camptothecin Derivative 0.0295480456086947 0.67592671
NSC 682764 Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- 0.0295480456086947 -0.098083141
Total:54  Current:37    [First] [Prev] [Next] [Last]